The state of the art Laboratory and clinic at World Stem Cells Clinic announces its latest in Stem Cell Treatments and procedures to rejuvenate the face, body, organs and increase the feeling of well being.

Lutz, Florida (PRWEB) February 07, 2013

The Stem Cell Treatment at World Stem Cells Clinic takes 5 days to complete as the treatments are comprehensive and designed to maximize the benefits and safety a patient derive from the process.

World Stem Cells, LLC worldstemcells.com will provide patient management service assisting the patient on their flight, hotel, provide transportation to and from the airport, transportation to and from your hotel to World Stem Cells Clinic, provide 24/7 communication and be the patients ombudsmen.

FACTS ABOUT AGING

The science shows each minute, our body is dying, this is a fact. Each minute that passes by our body has lost 300,000,000 cells. That means the cells that die in our body equals the population of the United States, each and every single minute. As we age less and less of those cells are replace and we slowly decay. Doctors have see people over a 100 that if cut nothing happens as there are no cells to close the wound.

Thus Aging is a result of progressive depletion of stem cells, so the introduction of new stem cells and adjunctive treatments has the potential of slowing down or reversing this process. Stem cells possess a unique anti-aging effect by regenerating and repairing organs, improving immune function, repair damaged by stress, and various toxins we are exposed to in our daily life.

Stem Cells often thought of as futuristic, controversial and unknown, are now providing the latest anti-Aging, rejuvenation and beauty secret.

THE SIGNS OF AGING

The signs of aging generally start at 40, earlier for those who have burned the candle at both ends , smokers, have been under stress or in contact with toxic sustenances and generally later for those who have had less stress, non smokers, exercised and eat properly but in the end we all will age. Some of the signs of aging are:

Continued here:
Living to 100 with Anti-Aging and Rejuvenation Stem Cells Therapy

Thediscovery of until now elusive taste stem cells on the tongue will help researchers and industry better understand the complexities of human taste, say researchers.

The breakthrough, byresearchers at the Monell Chemical Sciences Center, USA, will help to develop new techniques to grow and manipulate fully functional taste cells for use in research and clinical treatments, say thescientists behind the finding.

Writing in the journal Stem Cells,the Monell team explains that for decades taste scientists have attempted to identify the stem - or progenitor - cells that spawn the different taste receptor cells. This elusive challenge also sought to establish whether one, or several, progenitors were involved, and where they were located, they said.

Led by senior author Dr Peihua Jiang, the research team said that the identification of the location and certain genetic characteristics of taste stem cells on the tongue will kick-start research that better understands the make-up of human taste, and could someday help treat clinical taste dysfunctions.

"This is just the tip of the iceberg," said Jiang. "Identification of these cells opens up a whole new area for studying taste cell renewal, and contributes to stem cell biology in general."

"Cancer patients who have taste loss following radiation to the head and neck and elderly individuals with diminished taste function are just two populations who could benefit from the ability to activate adult taste stem cells," explained Dr Robert Margolskee, who also worked on the study.

Tasty findings

The team explained that taste cells are located in clusters called taste buds, which in turn are found in papillae, the raised bumps visible on the tongue's surface. In these structures, there are two types of taste cells that contain the chemical receptors that initiate perception of sweet, bitter, umami, salty, and sour taste qualities while a third type appears to serve as a supporting cell.

A remarkable characteristic of these sensory cells is that they regularly regenerate, said the researchers. All three taste cell types undergo frequent turnover, with an average lifespan of 10-16 days. As such, new taste cells must constantly be regenerated to replace cells that have died.

Read more from the original source:
Monell scientists identify taste stem cells on the tongue

Can stem cells provide an answer to the perplexing question of how to ensure long-term survival of transplanted kidneys? The results of a new Phase 1 clinical trial say maybe so. Details of the trial, conducted by researchers at Leiden University Medical Center, The Netherlands, are published in the current issue of STEM CELLS Translational Medicine.

Durham, NC (PRWEB) February 07, 2013

The LUMC team, led by Marlies E.J. Reinders, M.D, Ph.D., and Ton J. Rabelink, M.D., Ph.D., decided to test whether stem cells might keep fibrosis in check. They focused on mesenchymal stromal cells, a type of stem cell found throughout the body, including in bone marrow.

Mesenchymal stromal cells (MSCs) are an interesting candidate due to their immunosuppressive and regenerative properties, Dr. Reinders explained. Of importance, no clinical studies have investigated their effects on rejection and fibrosis in organ transplantation.

The team performed a safety and feasibility study in kidney transplant patients who, at four weeks or six months after transplant, were showing signs of rejection and/or an increase in fibrosis and wasting away of the kidneys tubes (a condition called interstitial fibrosis/tubular atrophy. . In all, six patients received two intravenous MSC infusions of 1 million cells, collected from the patients own bone marrow and given one week apart. None of the patients had any sign of adverse, treatment-related side effects from the MSCs, although three developed infections associated with immune suppression.

Five of the patients had a specific decrease in immunity against the transplanted organ. In agreement, prior to the infusions, two of the patients had tubulitis lesions that are a warning sign of organ rejection which disappeared after the MSC treatment.

These first clinical observations support the potential of stem cells as a novel cell therapy to prevent allograft rejection and interstitial fibrosis/tubular atrophy, Dr. Rabelink noted, adding that long-term follow-up to better understand MSC-based treatment and to monitor unwanted side effects is needed, especially since transplant recipients are already at an increased risk for infection and malignancies.

While the study wasnt designed to test efficacy, these clinical observations are promising and suggestive of systemic immunosuppression, said Anthony Atala, M.D., Editor of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine.

###

The full article, Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study, can be accessed at http://stemcellstm.alphamedpress.org/content/early/2013/01/23/sctm.2012-0114.abstract.

Follow this link:
Stem Cells Show Promise in Extending Transplanted Kidneys’ Survival Time